Figure 4From: An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort Kaplan-Meier plots illustrating patient outcome according to ERCC1 -19q13 status in the colon cancer subgroup. A: Overall survival, B: Time to recurrence. Hazard ratios presented are Kaplan-Meier estimates of survival probabilities with corresponding 95% confidence intervals.Back to article page